The multifunctional role of vitamin K2 in biological systems
Abstract
The increasing prevalence of non-communicable diseases and an aging population are driving interest in micronutrients capable of modulating coordinated metabolic and signaling networks. Vitamin K 2 (menaquinones) is traditionally considered a cofactor of γ-glutamyl carboxylase in the vitamin K cycle, which provides γ-carboxylation of vitamin K-dependent proteins. At the same time, recent data indicate broader extrahepatic effects that link the carboxylation status of osteocalcin and matrix Gla protein to bone mineralization and vascular calcification processes, as well as pointing to potential non-carboxylation mechanisms in the regulation of redox balance, inflammation, and cellular metabolism. The aim of the study was to systematize current knowledge on the molecular mechanisms and tissue-specific effects of vitamin K 2 (mainly MK-4 and MK-7) in hemostasis, the bone-vessel axis, metabolic-endocrine regulation, immune-inflammatory responses, and neurobiology, identifying gaps in the evidence base for clinical translation. A narrative synthesis with elements of a scoping approach was performed based on a search in PubMed/MEDLINE, Scopus, and Web of Science; priority was given to randomized studies, meta-analyses, and cohort studies supported by in vitro/in vivo mechanistic data. Biomarkers of vitamin K functional status, in particular dp-ucMGP and uncarboxylated osteocalcin, were analyzed separately. Therefore, the effects of K 2 are context-dependent and determined by the form of menaquinone, dose, duration, and baseline vitamin K status; MK-7 is characterized by more stable pharmacokinetics and better extrahepatic carboxylation. The heterogeneity of clinical outcomes justifies the need for standardized interventions, biomarker-oriented stratification, and the selection of clinically meaningful endpoints (calcification, fractures) with parallel asses s ment of redox and inflammatory signaling pathways. Promising avenues include evaluating the neu roprotective pote ntial of K 2 in well-designed studies.References
AlBlooshi, S. (2025). Vitamin K and women”s health: A review. Frontiers in Global Women’s Health, 6, 1590414.
Alisi, L., Cao, R., De Angelis, C., Cafolla, A., Caramia, F., Cartocci, G.,... & Fiorelli, M. (2019). The relationships between vitamin K and cognition: A review of current evidence. Frontiers in Neurology, 10, 239.
Al-Suhaimi, E. A., Alotaibi, M. F., & Alotaibi, A. S. (2014). Vitamin K2 inhibits proliferation of hepatocellular carcinoma cells. Asian Pacific Journal of Cancer Prevention, 15(20), 8855–8860.
Azuma, K., & Inoue, S. (2019). Multiple modes of vitamin K actions in aging-related musculoskeletal disorders. International Journal of Molecular Sciences, 20(11), 2844.
Badmaev, V., Prakash, L., & Majeed, M. (2011). Vitamin K2 prevents osteoclast activation by modulating RANKL/RANK system. Nutrition, 27(11–12), 1189–1194.
Bai, H., Kawahara, M., & Takahashi, M. (2023). Identification of menaquinone-4 (vitamin K2) target genes in bovine endometrial epithelial cells in vitro. Theriogenology, 198, 183–193.
Bellone, F., Cinquegrani, M., Nicotera, R., Carullo, N., Casarella, A., Presta, P., ... & Coppolino, G. (2022). Role of vitamin K in chronic kidney disease: A focus on bone and cardiovascular health. International Journal of Molecular Sciences, 23(9), 5282.
Beulens, J. W. J., Bots, M. L., Atsma, F., Bartelink, M. L., Prokop, M., Geleijnse, J. M., … & Grobbee, D. E. (2009). High dietary menaquinone intake is associated with reduced coronary calcification. Atherosclerosis, 203(2), 489–493.
Bonaldo, F., & Leroy, F. (2024). Bacterially produced vitamin K2 and its potential to generate health benefits in humans. Trends in Food Science and Technology, 147, 104461.
Booth, S. L., & Rajabi, H. (2008). Vitamin K: Dietary intakes and status. Current Opinion in Clinical Nutrition and Metabolic Care, 11(1), 53–57.
Caluwé, R., Vandecasteele, S., Van Vlem, B., Vermeer, C., & De Vriese, A. S. (2014a). Vitamin K2 supplementation in haemodialysis patients: A randomized dose-finding study. Nephrology Dialysis Transplantation, 29(7), 1385–1390.
Caluwé, R., Verbeke, F., De Vriese, A. S., & Vermeer, C. (2014b). A randomized trial of vitamin K supplementation in hemodialysis patients: Effect on matrix Gla protein levels and vascular stiffness. Journal of Bone and Mineral Research, 29(10), 2237–2244.
Capozzi, A., Scambia, G., Lello, S., & Pontecorvi, A. (2020). Calcium, vitamin D, vitamin K2, and magnesium: A review of their role in bone health. Clinical Nutrition, 39(10), 2910–2920.
Choi, H. J., Yu, J., Choi, H., An, J. H., Kim, S. W., Park, K. S., … & Shin, C. S. (2011). Vitamin K2 supplementation improves insulin sensitivity via osteocalcin metabolism: A placebo-controlled trial. Diabetes Care, 34(9), e147.
Chouet, J., Ferland, G., Féart, C., Rolland, Y., Presse, N., Boucher, K.,... & Annweiler, C. (2015). Dietary vitamin K intake is associated with cognition and behaviour among geriatric patients: The CLIP study. Nutrients, 7(8), 6739–6750.
Cranenburg, E. C. M., Schurgers, L. J., Uiterwijk, H. H., Beulens, J. W. J., Dalmeijer, G. W., Westerhuis, R., … Vermeer, C. (2009). Matrix Gla-protein, a marker of vascular calcification, is associated with cardiovascular risk. Thrombosis and Haemostasis, 101(6), 1037–1043.
Dalmeijer, G. W., van der Schouw, Y. T., Magdeleyns, E. J., Schurgers, L. J., Vermeer, C., & Beulens, J. W. J. (2013). Matrix Gla protein species and coronary artery calcification. Atherosclerosis, 227(2), 459–463.
Dam, V., Dalmeijer, G. W., Vermeer, C., Drummen, N. E., Knapen, M. H., Van Der Schouw, Y. T., & Beulens, J. W. (2015). Association between vitamin K and the metabolic syndrome: A 10-year follow-up study in adults. The Journal of Clinical Endocrinology and Metabolism, 100(6), 2472–2479.
Dharmaraj, K., Román Silva, J. I., Kahlert, H., Lendeckel, U., & Scholz, F. (2020). The acid-base and redox properties of menaquinone MK-4, MK-7, and MK-9 (vitamin K2) in DMPC monolayers on mercury. European Biophysics Journal, 49(3), 279–288.
Duan, F., Yu, Y., Guan, R., Xu, Z., Liang, H., & Hong, L. (2016). Vitamin K2 induces mitochondria-related apoptosis in human bladder cancer cells via ROS and JNK/p38 MAPK signal pathways. PLoS One, 11(8), e0161886.
Dupuy, M., Bondonno, N. P., Pokharel, P., Linneberg, A., Levinger, I., Schultz, C., ... & Sim, M. (2025). Vitamin K: Metabolism, genetic influences, and chronic disease outcomes. Food Science and Nutrition, 13(6), e70431.
Ellis, J. L., Karl, J. P., Oliverio, A. M., Fu, X., Soares, J. W., Wolfe, B. E., & Booth, S. L. (2021). Dietary vitamin K is remodeled by gut microbiota and influences community composition. Gut Microbes, 13(1), 1887721.
Emanuelli, B., Bianchi, M., & Pellegrini, S. (2000). SOCS proteins: Negative regulators of cytokine signaling. Trends in Endocrinology and Metabolism, 11(9), 380–385.
Evenepoel, P., Claes, K., Meijers, B., Laurent, M., Bammens, B., Naesens, M., … Kuypers, D. (2014). Poor vitamin K status is associated with vascular calcification and arterial stiffness in chronic kidney disease. Nephrology Dialysis Transplantation, 29(11), 2083–2090.
Evenepoel, P., Goffin, E., Meijers, B., Laurent, M., Bammens, B., Vanassche, T., … Schurgers, L. J. (2015). Matrix Gla protein is associated with mortality and cardiovascular events in hemodialysis patients. Nephrology Dialysis Transplantation, 30(4), 679–685.
Ferland, G. (2012). Vitamin K and the nervous system: An overview of its actions. Advances in Nutrition, 3(2), 204–212.
Furie, B., Bouchard, B. A., & Furie, B. C. (1999). Vitamin K-dependent biosynthesis of γ-carboxyglutamic acid. Blood, 93(6), 1798–1808.
Fusaro, M., Gallieni, M., Rizzo, M. A., Stucchi, A., Delanaye, P., Cavalier, E., … Evenepoel, P. (2017). Vitamin K plasma levels determination in human health. Clinical Chemistry and Laboratory Medicine, 55(6), 789–799.
Gasieva, D. M., Sheremetyeva, E. V., Kalashnikova, M. F., Dzgoeva, F. K., & Alborova, E. T. (2024). Polycystic ovary syndrome: New and promising treatment methods. Problemy Endokrinologii, 70(4), 103–113.
Gast, G. C. M., de Roos, N. M., Sluijs, I., Bots, M. L., Beulens, J. W. J., Geleijnse, J. M., ... & van der Schouw, Y. T. (2009). A high menaquinone intake reduces the incidence of coronary heart disease. Nutrition, Metabolism and Cardiovascular Diseases, 19(7), 504–510.
Halder, M., Petsophonsakul, P., Akbulut, A. C., Pavlic, A., Bohan, F., Anderson, E., ... & Schurgers, L. (2019). Vitamin K: Double bonds beyond coagulation insights into differences between vitamin K1 and K2 in health and disease. International Journal of Molecular Sciences, 20(4), 896.
Hao, Z., Jin, D.-Y., Stafford, D. W., & Tie, J.-K. (2019). Vitamin K-dependent carboxylation of coagulation factors: Insights from a cell-based functional study. Haematologica, 105(8), 2164–2173.
Hariri, E., Kassis, N., Iskandar, J. P., Schurgers, L. J., Saad, A., Abdelfattah, O., ... & Kapadia, S. (2021). Vitamin K2 – a neglected player in cardiovascular health: A narrative review. Open Heart, 8(2), e001715.
Hitomi, Y., Nozaki, J., Terao, J., & Yamanaka, M. (2005). Vitamin K2 (menatetrenone) inhibits hepatocellular carcinoma cell growth by regulating cell cycle. Cancer Letters, 229(1), 51–60.
Inoue, T., Fujita, T., & Kishimoto, H. (2009). Randomized study of the effect of vitamin K2 on bone loss in patients with osteoporosis. Journal of Orthopaedic Science, 14(4), 566–572.
Ismael, K. I., Al-Maliki, R. S., & Al-Tameem, A. A. (2025). DNA fragmentation and vitamin K2 levels in sperm maturation and apoptosis. Indonesian Journal on Health Science and Medicine, 2(2), 117.
Ivanova, D., Zhelev, Z., Getsov, P., Nikolova, B., Aoki, I., Higashi, T., & Bakalova, R. (2018). Vitamin K: Redox-modulation, prevention of mitochondrial dysfunction and anticancer effect. Redox Biology, 16, 352–358.
Iwamoto, J., Sato, Y., Takeda, T., & Matsumoto, H. (2014). Vitamin K2 therapy for postmenopausal osteoporosis. Nutrition Research, 34(6), 489–495.
Iwamoto, J., Takeda, T., & Sato, Y. (2013). Effects of vitamin K2 on osteoporosis. Current Pharmaceutical Design, 19(8), 1352–1359.
Jadhav, N., Ajgaonkar, S., Saha, P., Gurav, P., Pandey, A., Basudkar, V., … & Nair, S. (2022). Molecular pathways and roles for vitamin K2-7 as a health-beneficial nutraceutical: Challenges and opportunities. Frontiers in Pharmacology, 13, 896920.
Kampmann, F. B., Thysen, S. M., Nielsen, C. F. B., Kofoed, K. F., Køber, L., Pham, M. H. C., ... & Linneberg, A. (2023). Study protocol of the InterVitaminK trial: A Danish population-based randomised double-blinded placebo-controlled trial of the effects of vitamin K (menaquinone-7) supplementation on cardiovascular, metabolic and bone health. BMJ Open, 13(5), e071885.
Kaneki, M., Hosoi, T., Ouchi, Y., & Orimo, H. (2001). Japanese fermented soybean food natto contains vitamin K2 (menaquinone-7) and improves bone mineral density in postmenopausal women. Nutrition, 17(3), 215–220.
Kaźmierczak-Barańska, J., Boguszewska, K., & Karwowski, B. T. (2024). The protective role of vitamin K in aging and age-related diseases. Nutrients, 16(24), 4341.
Khalil, N., Elshafie, A., & El-Aziz, A. A. (2021). Decreased bone mineral density, vitamin K and vitamin D status in patients with inflammatory bowel disease. Medicina Clínica Práctica, 4(4), 100191.
Khan, F., Elsori, D., Verma, M., Pandey, S., Obaidur Rab, S., Siddiqui, S., ... & Pandey, P. (2024). Unraveling the intricate relationship between lipid metabolism and oncogenic signaling pathways. Frontiers in Cell and Developmental Biology, 12, 1399065.
Knapen, M. H. J., Drummen, N. E., Smit, E., Vermeer, C., & Theuwissen, E. (2013). Three-year low-dose menaquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women. Osteoporosis International, 24(9), 2499–2507.
Lai, Y., Hori, M., Ma, Y., Guo, Y., & Zhang, B. (2022). Role of vitamin K in intestinal health. Frontiers in Immunology, 12, 791565.
Li, J., Wang, H., & Rosenberg, P. A. (2009). Vitamin K prevents oxidative cell death by inhibiting activation of 12-lipoxygenase in developing oligodendrocytes. Journal of Neuroscience Research, 87(9), 1997–2005.
Li, Q. Y., Zhang, X., Wang, Y., & Zhao, L. (2018). Vitamin K2 suppresses NF-κB activation and ameliorates insulin resistance. Journal of Cellular Physiology, 233(1), 423–434.
Li, T., Wang, Y., & Tu, W. P. (2023). Vitamin K supplementation and vascular calcification: A systematic review and meta-analysis of randomized controlled trials. Frontiers in Nutrition, 10, 1115069.
Lyytinen, A. T., & Linneberg, A. (2023). Vitamin K – a scoping review for Nordic Nutrition Recommendations 2023. Food and Nutrition Research, 67, 10260.
Mahdinia, E., Jafari, M., & Ebrahimi, A. (2019). Production of vitamin K2 (menaquinone-7) by Bacillus subtilis: A review. Journal of Functional Foods, 59, 262–273.
Manna, P., & Kalita, J. (2016). Beneficial role of vitamin K supplementation on insulin sensitivity, glucose metabolism, and the reduced risk of type 2 diabetes: A review. Nutrition, 32(7–8), 732–739.
Mathews, N., & Hayward, C. P. M. (2025). Vitamin K deficiency: Diagnosis and management. Annals of Laboratory Medicine, 45(4), 358–366.
Mehta, S., Akbarian, S., & Yadav, V. (2017). Gas6 and vitamin K2 in myelin repair. Journal of Neuroscience Research, 95(1–2), 246–257.
Mladěnka, P., Macáková, K., Křížová, L., & Boušová, I. (2022). Vitamin K – sources, physiological role, kinetics, deficiency. Nutrition Reviews, 80(4), 677–695.
Narvaez, C. J., Bak, M. J., Salman, N., & Welsh, J. (2023). Vitamin K2 enhances the tumor suppressive effects of 1,25(OH)2D3 in triple negative breast cancer cells. The Journal of Steroid Biochemistry and Molecular Biology, 231, 106307.
Nimptsch, K., Rohrmann, S., & Linseisen, J. (2008). Dietary intake of vitamin K and risk of prostate cancer in the Heidelberg cohort of the European Prospective Investigation into Cancer and Nutrition (EPIC-Heidelberg). American Journal of Clinical Nutrition, 87(4), 985–992.
Oikonomaki, T., Papasotiriou, M., Ntrinias, T., Kalogeropoulou, C., Zabakis, P., Kalavrizioti, D., ... & Papachristou, E. (2019). The effect of vitamin K2 supplementation on vascular calcification in haemodialysis patients: A 1-year follow-up randomized trial. International Urology and Nephrology, 51(11), 2037–2044.
Oldenburg, J., Watzka, M., & Bevans, C. G. (2008). The vitamin K cycle. Advances in Clinical Chemistry, 45, 1–26.
Ozaki, I., Zhang, H., Mizuta, T., Ide, Y., Eguchi, Y., Yasutake, T., ... & Yamamoto, K. (2007). Menatetrenone, a vitamin K2 analogue, inhibits hepatocellular carcinoma cell growth by suppressing cyclin D1 expression through inhibition of nuclear factor κB activation. Clinical Cancer Research, 13(7), 2236–2245.
Pan, X., Liu, Y., & Li, Y. (2016). Vitamin K2 inhibits inflammatory responses via NF-κB signaling pathway inactivation. Journal of Nutritional Biochemistry, 37, 106–114.
Popa, D. S., Bigman, G., & Rusu, M. E. (2021). The role of vitamin K in humans: Implication in aging and age-related diseases. Antioxidants, 10(4), 566.
Popescu, A., & German, M. (2021). Vitamin K2 holds promise for Alzheimer’s prevention and treatment. Nutrients, 13(7), 2206.
Puri, V., Arora, A., Sharma, A., Singhal, N., Pathak, D., & Chandra, R. (2011). Synthesis of novel vitamin K2 analogues with modification at the ω-terminal position and their biological evaluation as potent steroid and xenobiotic receptor (SXR) agonists. Journal of Medicinal Chemistry, 54(11), 3793–3801.
Rahimi Sakak, F., Amini, M., & Aminorroaya, A. (2021). Glycemic control improvement in individuals with type 2 diabetes with vitamin K2 supplementation: A randomized controlled trial. Journal of Research in Medical Sciences, 26, 43.
Roenn, S. H., Harsløf, T., Langdahl, B. L., & Dalby, H. R. (2016). Treatment with vitamin MK-7 prevents deterioration of bone mass and bone quality in postmenopausal women: A randomized placebo-controlled trial. Bone Abstracts, 5, OC1.3.
Rombouts, E. K., Rosendaal, F. R., & van der Meer, F. J. M. (2007). Daily vitamin K supplementation improves anticoagulant stability. Journal of Thrombosis and Haemostasis, 5(10), 2043–2048.
Roumeliotis, S., Cavallaro, R. A., Kontogiorgos, I., Neofytou, I. E., Maresz, K., Jeanne, J.-F., Miraglia, N., & Fuso, A. (2025). The epigenetic potential of vitamin K2 in brain health. Epigenomics, 17(10), 681–690.
Roumeliotis, S., Kontogiorgos, I., de Vries, F., Maresz, K., Jeanne, J. F., Leivaditis, K., & Schurgers, L. J. (2025b). The role of vitamin K2 in cognitive impairment: Linking vascular health to brain health. Frontiers in Aging Neuroscience, 16, 1527535.
Sato, T., Inaba, N., & Yamashita, T. (2020). MK-7 and its effects on bone quality and strength. Nutrients, 12(4), 965.
Sato, T., Schurgers, L. J., & Uenishi, K. (2012). Comparison of menaquinone-4 and menaquinone-7 bioavailability in healthy women. Nutrition Journal, 11, 93.
Sato, Y., Honda, Y., Iwamoto, J., Kanoko, T., & Satoh, K. (2005). Menatetrenone (vitamin K2) and vitamin D2 supplementation improves bone mineral density in elderly women with Alzheimer’s disease. Bone, 36(1), 61–68.
Scheiber, D., Veulemans, V., Horn, P., Chatrou, M. L. L., Potthoff, S. A., Knapen, M. H. J., … Schurgers, L. J. (2015). High-dose menaquinone-7 supplementation reduces medial arterial calcification in rats treated with warfarin. Nutrients, 7(7), 5198–5216.
Schurgers, L. J., & Vermeer, C. (2002). Differential lipoprotein transport pathways of K-vitamins in healthy subjects. Biochimica et Biophysica Acta – Molecular Basis of Disease, 1570(1), 27–32.
Schurgers, L. J., Aebert, H., Vermeer, C., Bültmann, B., & Janzen, J. (2004). Oral anticoagulant treatment: Friend or foe in cardiovascular disease? Blood, 104(11), 3231–3232.
Schurgers, L. J., Teunissen, K. J. F., Hamulyák, K., Ten Cate, H., & Vermeer, C. (2008). Matrix Gla-protein: The calcification inhibitor in need of vitamin K. Thrombosis and Haemostasis, 100(4), 593–603.
Schwalfenberg, G. K. (2017). Vitamins K1 and K2: The emerging group of vitamins required for human health. Journal of Nutrition and Metabolism, 2017, 6254836.
Shahdadian, F., Neyestani, T. R., & Gharavi, A. (2018). Effect of vitamin K supplementation on glycemic control: A systematic review and meta-analysis. Experimental and Clinical Endocrinology and Diabetes, 126(S1), S48–S53.
Shea, M. K., Berkner, K. L., Ferland, G., Fu, X., Holden, R. M., & Booth, S. L. (2021). Perspective: evidence before enthusiasm – a critical review of the potential cardiovascular benefits of vitamin K. Advances in Nutrition, 12(3), 632–646.
Shearer, M. J., & Newman, P. (2008). Metabolism and cell biology of vitamin K. Thrombosis and Haemostasis, 100(4), 530–547.
Shearer, M. J., Fu, X., & Booth, S. L. (2014). Recent trends in the metabolism and cell biology of vitamin K. Journal of Nutritional Biochemistry, 25(1), 1–15.
Shiraki, M., Shiraki, Y., Aoki, C., & Miura, M. (2000). Vitamin K2 (menatetrenone) effectively prevents fractures and sustains lumbar bone mineral density in osteoporosis. Journal of Bone and Mineral Research, 15(3), 515–521.
Simes, D. C., Viegas, C. S. B., Araújo, N., Marreiros, C., & Viegas, C. (2019). Vitamin K as a powerful micronutrient in aging and age-related diseases: Pros and cons from clinical studies. International Journal of Molecular Sciences, 20(17), 4150.
Smajdor, J., & Bettmann, H. (2023). The impact of gut bacteria producing long-chain homologs of vitamin K2 on human health. Cancer Cell International, 23, 3114.
Soutif-Veillon, A., Ferland, G., Rolland, Y., Presse, N., Boucher, K., Féart, C., ... & Annweiler, C. (2016). Increased dietary vitamin K intake is associated with less severe subjective memory complaint among older adults. Maturitas, 93, 131–136.
Spronk, H. M., Soute, B. A., Schurgers, L. J., Thijssen, H. H., De Mey, J. G., & Vermeer, C. (2003). Tissue-specific utilization of menaquinone-4 results in the prevention of arterial calcification in warfarin-treated rats. Journal of Vascular Research, 40(6), 531–537.
Su, X., Wang, W., Zhang, H., & Fang, C. (2021). Vitamin K2 alleviates insulin resistance in skeletal muscle via regulating T-cadherin biology and mitochondrial function. Antioxidants and Redox Signaling, 35(15), 1212–1228.
Suksomboon, N., Poolsup, N., & Darliyingreungjaroen, W. (2017). Effect of vitamin K supplementation on insulin sensitivity: A meta-analysis. Diabetes and Metabolic Syndrome: Clinical Research and Reviews, 11(S1), S473–S477.
Tarkesh, F., Namavar Jahromi, B., Hejazi, N., & Tabatabaee, H. (2020). Beneficial health effects of menaquinone-7 on body composition, glycemic indices, lipid profile, and endocrine markers in polycystic ovary syndrome patients. Food Science and Nutrition, 8(10), 5612–5621.
Theuwissen, E., Cranenburg, E. C. M., Knapen, M. H. J., Magdeleyns, E. J., Teunissen, K. J. F., Schurgers, … & Vermeer, C. (2012). Low-dose menaquinone-7 supplementation improves extra-hepatic vitamin K status, but has no effect on thrombin generation in healthy subjects. British Journal of Nutrition, 108(9), 1652–1657.
Toki, E., Goto, S., Setoguchi, S., Terada, K., Watase, D., Yamakawa, H., … & Takata, J. (2022). Delivery of the reduced form of vitamin K2(20) to NIH/3T3 cells partially protects against rotenone induced cell death. Scientific Reports, 12(1), 19878.
van Ballegooijen, A. J., & Beulens, J. W. J. (2017). The synergistic interplay between vitamins D and K for bone and cardiovascular health. Frontiers in Nutrition, 4, 20.
van der Velden, T. T., Kayastha, K., Waterham, C. Y., Brünle, S., & Jeuken, L. J. (2025). Menaquinone-specific turnover by Mycobacterium tuberculosis cytochrome bd is redox regulated by the Q-loop disulfide bond. Journal of Biological Chemistry, 301(2), 108094.
Veronese, N., Bolzetta, F., De Rui, M., Maggi, S., Noale, M., Zambon, S., … & Manzato, E. (2015). Use of vitamin K antagonists and fracture risk: Results from a systematic review and meta-analysis. Journal of Thrombosis and Haemostasis, 13(9), 1665–1675.
Villa-Bellosta, R. (2020). Vascular calcification and vitamin K. Nutrients, 12(8), 2347.
Vlasschaert, C., Goss, C. J., Pilkey, N. G., McKeown, S., & Holden, R. M. (2020). Vitamin K supplementation for the prevention of cardiovascular disease: Where is the evidence? A systematic review of controlled trials. Nutrients, 12(10), 2909.
Vos, M., Esposito, G., Edirisinghe, J. N., Vilain, S., Haddad, D. M., Slabbaert, J. R., … & Verstreken, P. (2012). Vitamin K2 is a mitochondrial electron carrier that rescues pinK1 deficiency. Science, 336(6086), 1306–1310.
Vossen, L. M., Drolenga, M., Schurgers, L. J., & Knapen, M. H. J. (2021). Menaquinone-7 supplementation and vitamin K antagonist therapy: Effects on vitamin K status and coagulation. Nutrients, 13(6), 2029.
Vossen, L. M., Schurgers, L. J., Van Varik, B. J., Kietselaer, B. L. J. H., Vermeer, C., & Dweck, M. R. (2020). The role of vitamin K-dependent proteins in vascular calcification: A systematic review. Nutrients, 12(9), 2702.
Wasilewski, G. B., Vervloet, M. G., & Schurgers, L. J. (2019). The bone–vasculature axis: Calcium supplementation, vitamin D and vitamin K2. Frontiers in Cardiovascular Medicine, 6, 6.
Weiss, P., Maslanka, M., & Harker, L. A. (1987). Decline of proteins C and S and factors II, VII, IX and X during the initiation of warfarin therapy. Thrombosis Research, 45(6), 793–806.
Welsh, J., Bak, M. J., & Narvaez, C. J. (2022). New insights into vitamin K biology with relevance to cancer. Trends in Molecular Medicine, 28(10), 864–881.
Wen, L., Chen, J., Duan, L., & Li, S. (2018). Vitamin K-dependent proteins involved in bone and cardiovascular health. Molecular Medicine Reports, 18(1), 3–15.
Wu, S., Sun, X., Fan, T., Lin, F., Chi, Y., Yang, H., & Zhao, C. (2025). Metabolic engineering strategy for Bacillus subtilis producing MK-7. Foods, 14(23), 4150.
Wu, Y., Zhang, X., Li, Z., & Wang, Y. (2019). Vitamin K2 modulates osteoblast differentiation via regulation of osteoprotegerin/RANKL ratio. Journal of Bone and Mineral Metabolism, 37(4), 609–619.
Xie, C., Luo, Y., Jin, X., Xu, W., & Hu, J. (2024). Effects of vitamin K supplementation on bone mineral density: A systematic review and meta-analysis. Journal of Orthopaedic Translation, 46, 30–42.
Xv, F., Chen, J., Duan, L., & Li, S. (2018). Research progress on the anticancer effects of vitamin K2. Oncology Letters, 15(6), 8926–8934.
Yan, Q., Zhang, T., O’Connor, C., Barlow, J. W., Walsh, J., Scalabrino, G., … & Sheridan, H. (2023). The biological responses of vitamin K2: A comprehensive review. Food Science and Nutrition, 11(4), 1634–1656.
Zhang, T., O’Connor, C., Sheridan, H., & Barlow, J. W. (2024). Vitamin K2 in health and disease: A clinical perspective. Foods, 13(11), 1646.
Zhang, Y., Liu, L., Wei, C., Wang, X., Li, R., Xu, X., … & Li, Y. (2023). Vitamin K2 supplementation improves impaired glycemic homeostasis and insulin sensitivity for type 2 diabetes through gut microbiome and fecal metabolites. BMC Medicine, 21, 174.
Zhang, Y., Wang, J., Liu, X., & Chen, Y. (2025). Vitamin K2 alleviates insulin resistance-associated skeletal muscle dysfunction. Journal of Cachexia, Sarcopenia and Muscle, 16(1), 45–60.
Zhang, Y., Zhang, X., Li, Y., Gao, Y., Li, S., & Wang, Z. (2022). Efficacy of vitamin K2 in the prevention and treatment of postmenopausal osteoporosis: A systematic review and meta-analysis of randomized controlled trials. Frontiers in Public Health, 10, 979649.
Zwakenberg, S. R., den Braver, N. R., Engelen, A. I. P., Feskens, E. J. M., Vermeer, C., Boer, J. M. A., … & Beulens, J. W. J. (2017). Vitamin K intake and all-cause and cause specific mortality. Clinical Nutrition, 36(5), 1294–1300.
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons «Attribution» 4.0 License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
